| Abstrakt: |
A report from researchers at Tongji University School of Medicine in Shanghai, China, discusses new findings on Alzheimer's disease (AD) treatment. The researchers propose a new approach using a protein called ReS19-T, which stabilizes the structure of septin filaments and improves the core pathology of AD by inhibiting abnormal calcium signaling pathways. However, further research is needed to investigate potential impacts on immune function and the relationship between ReS19-T and AD. The study suggests that Septin6 could be a promising avenue for AD treatment, but more research is needed to validate its therapeutic effect. [Extracted from the article] |
